Impact of Age and Severe Acute Respiratory Syndrome Coronavirus 2 Breakthrough Infection on Humoral Immune Responses After Three Doses of Coronavirus Disease 2019 mRNA Vaccine

BACKGROUND: Longer-term immune response data after 3 doses of coronavirus disease 2019 (COVID-19) mRNA vaccine remain limited, particularly among older adults and after Omicron breakthrough infection. METHODS: We quantified wild-type- and Omicron-specific serum immunoglobulin (Ig)G levels, angiotens...

Descripción completa

Detalles Bibliográficos
Autores principales: Mwimanzi, Francis, Lapointe, Hope R, Cheung, Peter K, Sang, Yurou, Yaseen, Fatima, Kalikawe, Rebecca, Datwani, Sneha, Burns, Laura, Young, Landon, Leung, Victor, Ennis, Siobhan, Brumme, Chanson J, Montaner, Julio S G, Dong, Winnie, Prystajecky, Natalie, Lowe, Christopher F, DeMarco, Mari L, Holmes, Daniel T, Simons, Janet, Niikura, Masahiro, Romney, Marc G, Brumme, Zabrina L, Brockman, Mark A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003738/
https://www.ncbi.nlm.nih.gov/pubmed/36910697
http://dx.doi.org/10.1093/ofid/ofad073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003738/
https://www.ncbi.nlm.nih.gov/pubmed/36910697
http://dx.doi.org/10.1093/ofid/ofad073

Ejemplares similares